Agios Pharmaceuticals Inc at Goldman Sachs Healthcare Conference Transcript
Great. Good morning, everyone. Thanks for joining us. I am Salveen Richter, biotechnology analyst at Goldman Sachs. And we're pleased to have the Agios team with us. So we have Brian Goff, CEO; as well as Sarah Gheuens, Chief Medical Officer.
Questions & Answers
Maybe to start here, Brian, you joined Agios as a CEO last year. And can you just discuss any notable changes in strategy in addition to where you stand on your lead (inaudible) commercial assets as well as the pipeline at this point?
Sure. Thanks a lot. First off, thanks so much for hosting us. We are thrilled to be here. We have a lot to talk about. It's a very exciting time for Agios. And the last year, for me personally and as well for Agios has been absolutely tremendous. We had many accomplishments, which we're very happy to talk
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
